Cohance Lifesciences Limited, the partner of choice for global innovative pharma companies, announces Rs. 23 crore investments and good progress on construction of its new cGMP oligonucleotide building block manufacturing facility located in
Zydus Lifesciences, a leading Indian pharmaceutical, is preparing to launch semaglutide variants, the active ingredient in antidiabetic and weight-loss drugs, as the patent nears expiration in 2026. The firm is expected to invest over ?100...
A new treatment by Pfizer’s Padcev and Merck’s Keytruda is showing positive results in patients with advanced bladder cancer. A recent study looked at these two drugs combined and showed that they helped patients live longer and delayed...
Novartis has announced positive top-line data from its Phase III NEPTUNUS-1 and NEPTUNUS-2 trials in active adult Sjögren's disease patients to assess ianalumab (VAY736) efficacy.
The international healthcare company Viatris Inc. reported that iron sucrose injection, USP, an injectable iron replacement product, has been approved by the US Food and Drug Administration (FDA) to treat iron deficiency anemia (IDA) in adult and ped
Sartorius Stedim Biotech, a collaborator with the biopharmaceutical industry, has entered into a collaboration with Nanotein Technologies, a developer of immune cell activation reagents. Sartorius Stedim Biotech intends to invest up to $3 million
Gland Pharma Limited, a generic injectable and ophthalmic company, has reported receiving a United States Food and Drug Administration
Zydus Lifesciences reported its consolidated revenue of Rs 65,737 million for Q1 FY26, highlighting a 6 percent YoY increase, while net profit rose 3 percent to Rs 14,668 million. The company has a strong foundation and plays
Asian Institute of Nephrology and Urology (AINU), India’s largest single-speciality chain focused on Uro-Nephro care, marks a new milestone with the expansion of its flagship hospital in Banjara Hills, Hyderabad. The flagship hospital has a combined
The All India Organization of Chemists and Druggists (AIOCD), which represents 10 lakh chemists in India, have asked Union Home Minister Amit Shah, to curtail the ability of quick-commerce platforms from selling prescription drugs...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
